Inventor
Anthony C. Blackburn
Inventor
San Diego, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
11,091,435Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P202110,981,895Crystalline forms and processes for the preparation of cannabinoid receptor modulators202110,927,123Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto202110,676,435Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders202010,662,200Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto202010,632,134Cannabinoid receptor modulators202010,479,797Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto201910,463,676Modified-release dosage forms of 5-HT201910,301,262Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders201910,226,471Modified-release dosage forms of 5-HT201910,183,930Crystalline forms and processes for the preparation of cannabinoid receptor modulators20199,867,822'Cannabinoid receptor modulators'20189,597,340'Cannabinoid receptor modulators'20179,492,447'Cannabinoid receptor modulators'20169,458,136'Crystalline forms and processes for the preparation of cannabinoid receptor modulators'20169,365,521'Non-hygroscopic salts of 5-HT2C agonists'20169,248,133'Salts of lorcaserin with optically active acids'20169,045,431'Processes for the preparation of 5-HT2C receptor agonists'20157,863,278'Isethionate salt of a selective CDK4 inhibitor'20117,345,171'Isethionate salt of a selective CKD4 inhibitor'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2011Based in Saline, MI, US· patent location history
2015–2021Patents assigned to ARENA PHARM INC (18)· patent assignee history
2015–2017Patents assigned to BLACKBURN ANTHONY C (5)· patent assignee history
2015–2016Patents assigned to SHIFRINA ANNA (3)· patent assignee history
2015–2021Based in San Diego, CA, US· patent location history
2016–2017Patents assigned to RUETER JAIMIE KARYN (3)· patent assignee history
2016–2017Patents assigned to HAN SANGDON (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 18 | 2015–2021 |
| BLACKBURN ANTHONY Cself | 5 | 2015–2017 |
| RUETER JAIMIE KARYN | 3 | 2016–2017 |
| SHIFRINA ANNA | 3 | 2015–2016 |
| HAN SANGDON | 2 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 18 | 2015–2021 |
| Saline, MI, US | 2 | 2008–2011 |